CAD improves polyp detection
CT colonography exams are difficult and time consuming to read and interpret, a potential barrier to more widespread colon cancer screening. Computer-aided detection has a potential role to play in that effort, according to a study presented at the
CT colonography exams are difficult and time consuming to read and interpret, a potential barrier to more widespread colon cancer screening. Computer-aided detection has a potential role to play in that effort, according to a study presented at the American Roentgen Ray Society meeting in May.
Dr. Abraham H. Dachman and colleagues at the University of Chicago retrospectively studied 20 CT colonography data sets: 10 sets consisted of 11 polyps, 5 to 12 mm in size, and 10 were normal. Four readers (two attending radiologists, a radiology resident, and a gastroenterologist) reviewed the data sets with and without computer-aided detection.
Readers missed 42% of the polyps without CAD; they later identified 75% of the missed polyps with the help of the CAD system. CAD detected all the polyps missed by the readers, while readers correctly dismissed 77% of the computer's false positives.
The average area under the ROC curve (Az values) for radiologists without and with CAD were 0.70 and 0.85, respectively. The difference was statistically significant. The increase in the Az value was the largest for the gastroenterologist (0.21) among the four observers.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
